Related references
Note: Only part of the references are listed.Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons
Lene Ryom et al.
AIDS (2014)
Tenofovir Plasma Concentrations According to Companion Drugs: a Cross-Sectional Study of HIV-Positive Patients with Normal Renal Function
A. Calcagno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Systematic Review of Antiretroviral-Associated Lipodystrophy: Lipoatrophy, but Not Central Fat Gain, Is an Antiretroviral Adverse Drug Reaction
Renee de Waal et al.
PLOS ONE (2013)
Differences in estimation of creatinine generation between renal function estimating equations in an Indian population: cross-sectional data from the Hyderabad arm of the Indian migration study
Phillippa K. Bailey et al.
BMC NEPHROLOGY (2013)
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Jim Young et al.
AIDS (2012)
Renal Function Declines More in Tenofovir-than Abacavir-Based Antiretroviral Therapy in Low-Body Weight Treatment-Naive Patients with HIV Infection
Takeshi Nishijima et al.
PLOS ONE (2012)
Tenofovir-Associated Kidney Toxicity in HIV-Infected Patients: A Review of the Evidence
Andrew M. Hall et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa
Wolfgang Stoehr et al.
ANTIVIRAL THERAPY (2011)
Tenofovir renal proximal tubular toxicity is regulated By OAT1 and MRP4 transporters
James J. Kohler et al.
LABORATORY INVESTIGATION (2011)
Systematic Review and Meta-analysis: Renal Safety of Tenofovir Disoproxil Fumarate in HIV-Infected Patients
Ryan D. Cooper et al.
CLINICAL INFECTIOUS DISEASES (2010)
Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India
Sanjay Pujari et al.
Journal of the International AIDS Society (2009)
Greater tenofovir-associated renal function decline with protease inhibitor-based versus nonnucleoside reverse-transcriptase inhibitor-based therapy
Miguel Goicoechea et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
No change in calculated creatinine clearance after tenofovir initiation among Thai patients
Angele Gayet-Ageron et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Share Paper
